MX2011005425A - Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada. - Google Patents

Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada.

Info

Publication number
MX2011005425A
MX2011005425A MX2011005425A MX2011005425A MX2011005425A MX 2011005425 A MX2011005425 A MX 2011005425A MX 2011005425 A MX2011005425 A MX 2011005425A MX 2011005425 A MX2011005425 A MX 2011005425A MX 2011005425 A MX2011005425 A MX 2011005425A
Authority
MX
Mexico
Prior art keywords
lantibiotic
antibacterial activity
enhanced antibacterial
carboxyamide derivatives
derivatives
Prior art date
Application number
MX2011005425A
Other languages
English (en)
Inventor
Sonia Ilaria Maffioli
Cristina Brunati
Donatella Potenza
Francesca Vasile
Stefano Donadio
Original Assignee
Sentinella Pharmaceuticals Inc Sentinella
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentinella Pharmaceuticals Inc Sentinella filed Critical Sentinella Pharmaceuticals Inc Sentinella
Publication of MX2011005425A publication Critical patent/MX2011005425A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención concierne a nuevos derivados amida del lantibiótico 97518 y a sus usos. En particular, la presente invención describe nuevos compuestos que tienen la Fórmula General (II) y sus usos como antibiótico.
MX2011005425A 2008-11-24 2008-11-24 Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada. MX2011005425A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2008/003184 WO2010058238A1 (en) 2008-11-24 2008-11-24 Lantibiotic carboxyamide derivatives with enhanced antibacterial activity

Publications (1)

Publication Number Publication Date
MX2011005425A true MX2011005425A (es) 2011-09-27

Family

ID=40668282

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011005425A MX2011005425A (es) 2008-11-24 2008-11-24 Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada.

Country Status (15)

Country Link
US (1) US20120053115A1 (es)
EP (1) EP2367845A1 (es)
JP (1) JP2012509866A (es)
KR (1) KR20110086582A (es)
CN (1) CN102224164A (es)
AR (1) AR074222A1 (es)
AU (1) AU2008364202A1 (es)
BR (1) BRPI0822946A2 (es)
CA (1) CA2742753A1 (es)
CL (1) CL2009002129A1 (es)
IL (1) IL213043A0 (es)
MX (1) MX2011005425A (es)
RU (1) RU2506272C2 (es)
TW (1) TW201023876A (es)
WO (1) WO2010058238A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
EA021683B1 (ru) 2009-01-14 2015-08-31 Новакта Биосистемс Лимитед Производные деоксиактагардина в
NZ594675A (en) 2009-02-04 2013-11-29 Novacta Biosystems Ltd Actagardine derivatives
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
EP2701718A4 (en) * 2011-03-30 2014-11-19 Sentinella Pharmaceuticals Inc LANTIBIOTIC NAI-802, PHARMACEUTICALLY ACCEPTABLE SALTS, ITS COMPOSITIONS, AND USES THEREOF
WO2014009763A1 (en) * 2012-07-12 2014-01-16 Naicons S.C.A.R.L. Novel lantipeptide
JP2016501232A (ja) * 2012-11-30 2016-01-18 ナイコンス，エセエッレエレＮａｉｃｏｎｓ，Ｓｒｌ 新規ランチビオティック誘導体およびその調製プロセス
KR20170102356A (ko) * 2015-01-19 2017-09-08 유니버시테이트 우트레크트 홀딩 비.브이. 니신계 화합물 및 이의 박테리아 감염의 치료 용도
CA3004805A1 (en) 2015-11-18 2017-05-26 Helmholtz-Zentrum Fur Infektionsforschung Gmbh Labyrinthopeptins as anti-viral agents
CN106188253B (zh) * 2016-08-26 2020-08-18 上海交通大学 抗菌肽Lexapeptide及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882313A (en) * 1987-07-31 1989-11-21 Smithkline Beckman Corporation Carboxamide derivatives of glycopeptides
EP0700998B1 (en) * 1994-09-12 2003-11-26 Aventis Pharma Deutschland GmbH Recombinant mersacidin and a method for production
IL122248A0 (en) * 1995-06-23 1998-04-05 Applied Microbiology Inc Use of nisin for treating an infection
DE19745583A1 (de) * 1997-10-15 1999-04-22 Hoechst Marion Roussel De Gmbh Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
EP1481986A1 (en) * 2003-05-30 2004-12-01 Vicuron Pharmaceuticals, Inc. Antibiotic 97518, pharmaceutically acceptable salts and compositions, and use thereof
CA2593818C (en) * 2005-01-12 2014-12-16 Vicuron Pharmaceuticals Inc. Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof

Also Published As

Publication number Publication date
US20120053115A1 (en) 2012-03-01
RU2506272C2 (ru) 2014-02-10
TW201023876A (en) 2010-07-01
EP2367845A1 (en) 2011-09-28
AR074222A1 (es) 2010-12-29
CA2742753A1 (en) 2010-05-27
BRPI0822946A2 (pt) 2015-06-23
IL213043A0 (en) 2011-07-31
AU2008364202A1 (en) 2011-07-07
CN102224164A (zh) 2011-10-19
RU2011125941A (ru) 2012-12-27
KR20110086582A (ko) 2011-07-28
WO2010058238A1 (en) 2010-05-27
JP2012509866A (ja) 2012-04-26
CL2009002129A1 (es) 2010-09-10

Similar Documents

Publication Publication Date Title
MX2011005425A (es) Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada.
ZA201002987B (en) Tropane compounds
TW200630367A (en) Substituted adenines and the uses thereof
PH12012501905A1 (en) Quinoline derivatives and their use as fungicides
MX2009006846A (es) Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
MX2010006143A (es) Azolilmetiloxiranos, su uso y agentes que lo contienen.
MY153915A (en) Organic compounds
WO2007115821A3 (en) Organic compounds
MX336381B (es) Boronatos como inhibidores de arginasa.
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
NZ616764A (en) Mannose derivatives as antagonists of bacterial adhesion
TW200700064A (en) Novel compounds
WO2011039735A3 (en) Compounds with ddx3 inhibitory activity and uses thereof
GB0508314D0 (en) Organic compounds
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
TW200942524A (en) Novel aminomethyl benzene derivatives
MX342947B (es) Tratamiento de diabetes tipo 2.
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
SG158091A1 (en) Imidazoazepinone compounds
GB2485117A (en) Substituted 1,2-azaborine heterocycles
TW200940659A (en) Azopyridone disperse dyes, their preparation and use
MX2008002294A (es) Derivados de pirimidina sustituida.
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.

Legal Events

Date Code Title Description
FG Grant or registration